Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Novak

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Neuromodulation : Journal of the International Neuromodulation Society|April 4, 2017
A Comparison of Unilateral Deep Brain Stimulation (DBS), Simultaneous Bilateral DBS, and Staged Bilateral DBS Lead AccuraciesSophia Peng, David Levine, Adolfo Ramirez-Zamora, et al.
Therapeutic Advances in Neurological Disorders|December 25, 2025
Efficacy of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy with or without diabetes: insights from a multicenter prospective comparative studySamir P Macwan, Shalini Mahajan, Peter Novak, et al.
Journal of Neuropathology and Experimental Neurology|April 17, 2026
Localization of mast cells in human brain tissue: Implications for neuropsychiatric symptoms in COVID-19Jennifer Nicoloro-SantaBarbara, Matthew P Giannetti, Isaac H Solomon, et al.
IEEE Transactions on Bio-Medical Engineering|June 16, 2011
Analysis of EMG and acceleration signals for quantifying the effects of deep brain stimulation in Parkinson's diseaseSaara M Rissanen, Markku Kankaanpää, Mika P Tarvainen, et al.
Muscle & Nerve|July 22, 2014
Natural history and biomarkers in hereditary sensory neuropathy type 1Vera Fridman, Anne Louise Oaklander, William S David, et al.
Cureus|November 18, 2022
Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative DiseasesJesus A Perez, Javier J Lopez, Claudia C Torres Badillo, et al.
Plos One|January 23, 2026
Shared autonomic phenotype of long COVID and myalgic encephalomyelitis/chronic fatigue syndromePeter Novak, David M Systrom, Alexandra Witte, et al.
Cureus|November 16, 2022
Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative DiseasesJesus A Perez, Javier J Lopez, Claudia C Torres Badillo, et al.
Journal of Neurology|April 28, 2022
MemAID: Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trialVera Novak, Christos S Mantzoros, Peter Novak, et al.
Neurology|January 11, 2019
Randomized trial of l-serine in patients with hereditary sensory and autonomic neuropathy type 1Vera Fridman, Saranya Suriyanarayanan, Peter Novak, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Neuromodulation : Journal of the International Neuromodulation Society|April 4, 2017
A Comparison of Unilateral Deep Brain Stimulation (DBS), Simultaneous Bilateral DBS, and Staged Bilateral DBS Lead AccuraciesSophia Peng, David Levine, Adolfo Ramirez-Zamora, et al.
Therapeutic Advances in Neurological Disorders|December 25, 2025
Efficacy of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy with or without diabetes: insights from a multicenter prospective comparative studySamir P Macwan, Shalini Mahajan, Peter Novak, et al.
Journal of Neuropathology and Experimental Neurology|April 17, 2026
Localization of mast cells in human brain tissue: Implications for neuropsychiatric symptoms in COVID-19Jennifer Nicoloro-SantaBarbara, Matthew P Giannetti, Isaac H Solomon, et al.
IEEE Transactions on Bio-Medical Engineering|June 16, 2011
Analysis of EMG and acceleration signals for quantifying the effects of deep brain stimulation in Parkinson's diseaseSaara M Rissanen, Markku Kankaanpää, Mika P Tarvainen, et al.
Muscle & Nerve|July 22, 2014
Natural history and biomarkers in hereditary sensory neuropathy type 1Vera Fridman, Anne Louise Oaklander, William S David, et al.
Cureus|November 18, 2022
Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative DiseasesJesus A Perez, Javier J Lopez, Claudia C Torres Badillo, et al.
Plos One|January 23, 2026
Shared autonomic phenotype of long COVID and myalgic encephalomyelitis/chronic fatigue syndromePeter Novak, David M Systrom, Alexandra Witte, et al.
Cureus|November 16, 2022
Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative DiseasesJesus A Perez, Javier J Lopez, Claudia C Torres Badillo, et al.
Journal of Neurology|April 28, 2022
MemAID: Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trialVera Novak, Christos S Mantzoros, Peter Novak, et al.
Neurology|January 11, 2019
Randomized trial of l-serine in patients with hereditary sensory and autonomic neuropathy type 1Vera Fridman, Saranya Suriyanarayanan, Peter Novak, et al.
Pageof 10